(Q40734999)

English

Trimethoprim-Sulfamethoxazole plus Amikacin as First-Line Therapy and Imipenem/Cilastatin as Second Empirical Therapy in Febrile Neutropenic Patients with Hematological Disorders

scientific article published on April 1, 1992

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Trimethoprim-Sulfamethoxazole plus Amikacin as First-Line Therapy and Imipenem/Cilastatin as Second Empirical Therapy in Febrile Neutropenic Patients with Hematological Disorders (English)

1 reference

10.1080/1120009X.1992.11739148

https://api.crossref.org/works/10.1080/1120009X.1992.11739148

17 October 2022

1 reference

based on heuristic

inferred from title

imipenem/cilastatin

1 reference

based on heuristic

inferred from title

1 reference

10.1080/1120009X.1992.11739148

https://api.crossref.org/works/10.1080/1120009X.1992.11739148

17 October 2022

1 reference

10.1080/1120009X.1992.11739148

https://api.crossref.org/works/10.1080/1120009X.1992.11739148

17 October 2022

author name string

P. A. Engervall

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1629753

17 October 2022

G. T. Stiernstedt

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1629753

17 October 2022

G. C. Günther

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1629753

17 October 2022

M. J. Björkholm

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1629753

17 October 2022

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1629753

17 October 2022

publication date

1 April 1992

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

full work available at URL

http://www.tandfonline.com/doi/pdf/10.1080/10256018808623883

1 reference

10.1080/1120009X.1992.11739148

https://api.crossref.org/works/10.1080/1120009X.1992.11739148

17 October 2022

Journal of Chemotherapy

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

99-106

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Quantitative Relationships Between Circulating Leukocytes and Infection in Patients with Acute Leukemia

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1992.11739148

21 January 2018

Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1992.11739148

21 January 2018

Prospective randomized comparison of three antibiotic regimens for empirical therapy of suspected bacteremic infection in febrile granulocytopenic patients

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1992.11739148

21 January 2018

Moxalactam plus piperacillin versus moxalactam plus amikacin in febrile granulocytopenic patients

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1992.11739148

21 January 2018

A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1992.11739148

21 January 2018

Imipenem-cilastatin as initial therapy for febrile cancer patients

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1992.11739148

21 January 2018

Gram-positive infections and the use of vancomycin in 550 episodes of fever and neutropenia

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1992.11739148

21 January 2018

Septicemia in patients with hematological disorders and neutropenia. A retrospective study of causative agents and their resistance profile.

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1992.11739148

21 January 2018

Combination of amikacin and carbenicillin with or without cefazolin as empirical treatment of febrile neutropenic patients. The International Antimicrobial Therapy Project Group of the European Organization for Research and Treatment of Cancer

8

1 reference

10.1080/1120009X.1992.11739148

https://api.crossref.org/works/10.1080/1120009X.1992.11739148

17 October 2022

Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia

9

1 reference

10.1080/1120009X.1992.11739148

https://api.crossref.org/works/10.1080/1120009X.1992.11739148

17 October 2022

Parenteral trimethoprim-sulfamethoxazole and carbenicillin as empiric therapy for neutropenic patients with cancer.

14

1 reference

10.1080/1120009X.1992.11739148

https://api.crossref.org/works/10.1080/1120009X.1992.11739148

17 October 2022

Carbenicillin-trimethoprim/sulfamethoxazole versus carbenicillin-gentamicin as empiric therapy of infection in granulocytopenic patients. A prospective, randomized, double-blind study

16

1 reference

10.1080/1120009X.1992.11739148

https://api.crossref.org/works/10.1080/1120009X.1992.11739148

17 October 2022

Thienamycin: development of imipenem-cilastatin

17

1 reference

10.1080/1120009X.1992.11739148

https://api.crossref.org/works/10.1080/1120009X.1992.11739148

17 October 2022

Imipenem/cilastatin as secondary therapy for infections in cancer patients

20

1 reference

10.1080/1120009X.1992.11739148

https://api.crossref.org/works/10.1080/1120009X.1992.11739148

17 October 2022

Identifiers

10.1080/1120009X.1992.11739148

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40734999&oldid=1753295212"